Eucalyptus Health was last valued at $1.1B (post-money). It comes from the $1.1B Acquisition by Hims & Hers of Feb 2026. Eucalyptus Health was acquired by Hims & Hers.
2 valuations. The latest, $1.1B post-money, was set by the Acquisition by Hims & Hers in Feb 2026.
A private valuation is the price agreed in one transaction. The Eucalyptus Health valuation of $1.1B is a post-money figure from the Acquisition by Hims & Hers dated 19 Feb 2026 — the whole company measured after the $1.1B raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $0 .
The valuation holds until the next priced round or secondary sale. A private company founded in 2019 with roughly 75 people has no daily price and no order book between rounds.
No. Eucalyptus Health was acquired by Hims & Hers; its shares do not trade independently.
The last valuation is $1.1B (post-money, Feb 2026).
Lead investors for each round are in the funding timeline.
The closest digital health / telehealth peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
